Semi-annual Performance Forecast for 2026
Filed with SSE · · 2 pages · Chinese
On 6ix: 6ix.com/news/shanghai-shyndec-pharmaceutical-co-ltdsemi-annual-performance-forecast-for-2026
Shanghai Shyndec Pharmaceutical Co., Ltd. on 6ix
Earlier from Shanghai Shyndec Pharmaceutical
- Announcement on Resolutions of the 5th Meeting of the 9th Board of Directors
- Announcement on Holding Subsidiary Obtaining Drug Registration Certificate
- Announcement on Obtaining Drug Registration Certificate by Subsidiary
- Announcement on Implementation of Dividend Distribution for 2025
- Announcement on Obtaining Drug Registration Certificate
Later from Shanghai Shyndec Pharmaceutical
- Announcement on the Wholly-owned Subsidiary's Drug Passing Generic Drug Consistency Evaluation
- Announcement on Obtaining Drug Registration Certificate by Wholly-owned Subsidiary
- Announcement on Progress of Signing of the "Drug Marketing Authorization Transfer Contract" by a Controlled Subsidiary
- Announcement on Resolutions of the 6th Meeting of the 9th Board of Directors
- Announcement on Wholly-owned Sub-subsidiary Obtaining Approval for Marketing of Chemical APIs
Follow Shanghai Shyndec Pharmaceutical into a list and get an email when it puts out news.
Follow Shanghai Shyndec Pharmaceutical